Initial rapidity of tumor growth as a prognostic factor for the therapeutic effect of immune-checkpoint inhibitors in patients with non-small cell lung cancer: evaluation for linear and non-linear correlation

BACKGROUND: Immune-checkpoint inhibitors (ICIs) have been increasingly used for non-small cell lung cancer (NSCLC) treatment in recent years. Although insufficient, the rate of programmed death-ligand 1 expression has been adopted as a predictor of ICI efficacy. We evaluated tumor growth rate as a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Kosuke, Kuramoto, Joji, Nishimura, Hiroaki, Kuwabara, Yoshiki, Kojima, Akitoshi, Sasaki-Toda, Maiko, Ogawa-Kobayashi, Yumiko, Kikuchi, Satoshi, Hirata, Yusuke, Mikami-Saito, Yuriko, Mikami, Shintaro, Kyoyama, Hiroyuki, Moriyama, Gaku, Gemma, Akihiko, Uematsu, Kazutsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411181/
https://www.ncbi.nlm.nih.gov/pubmed/34527329
http://dx.doi.org/10.21037/jtd-21-774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411181/
https://www.ncbi.nlm.nih.gov/pubmed/34527329
http://dx.doi.org/10.21037/jtd-21-774

Ejemplares similares